fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Procter & Gamble Health Ltd

Procter Gamble Health Ltd

Updated on November 12, 2019

Stock/Share Code - PGHL

Merck Limited is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments.

Below is the details of PGHL Procter Gamble Health Ltd

Market Cap₹6,830 Cr.
Current Price ₹4,301.2 as on 15 Nov 19
52 Week High / Low Price₹5,120.8 / ₹2,501
Face Value₹10
Stock P/E8.01
Book Value₹448.07
Dividend Yield10.69 %
ROCE78.16 %
ROE73.25 %
Sales Growth (3yrs)-3.32 %
SectorPharmaceuticals
IndustryPharmaceuticals - Multinational
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Stock is providing a good dividend yield of 10.69%. Company has good consistent profit growth of 71.59% over 5 years Company has a good return on equity (ROE) track record: 3 Years ROE 40.36% Company has been maintaining a healthy dividend payout of 45.56%
Cons: Stock is trading at 9.18 times its book value The company has delivered a poor growth of 1.25% over past five years. Tax rate seems low Earnings include an other income of Rs.761.47 Cr.

Procter Gamble Health Ltd Price Chart

Procter Gamble Health Ltd Price Chart

Procter Gamble Health Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Glaxosmi. Pharma ₹14.25 48.35 ₹20,586.22 Cr. 1.65 ₹113.54 Cr. 27.17 7.11 787.97 31.11
2. Abbott India ₹12,365 40.10 ₹19,440.78 Cr. 0.71 ₹116.94 Cr. 41.92 18.22 998.89 37.36
3. Sanofi India ₹6,487.65 36.36 ₹14,138.35 Cr. 1.37 ₹97.4 Cr. -2.21 9.41 747.90 28.84
4. Pfizer ₹3,980.75 29.74 ₹13,382.81 Cr. 0.77 ₹112.81 Cr. 22.83 6.26 544.40 23.22
5. Proc. Gam. Heal. ₹129.85 8.01 ₹6,830.07 Cr. 10.69 ₹44.08 Cr. -8.76 6.06 233.63 78.16
6. Astrazeneca Phar ₹2,622.85 67.59 ₹4,701.63 Cr. 0.00 ₹21.52 Cr. 236.78 26.71 204.56 26.51
7. Novartis India ₹69.35 62.57 ₹1,401.57 Cr. 1.76 ₹0.79 Cr. -92.10 -20.85 109.31 7.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Procter Gamble Health Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales269250229165206179198220226204231234
YOY Sales Growth %5.16%5.2%6.22%-37.96%-23.54%-28.53%-13.44%33.28%9.86%14.47%16.58%6.06%
Expenses223226206150169174174169168189181179
Material Cost %41.4%37.78%39.42%35.78%37.87%27.92%32.03%31.3%31.15%32.54%34.68%26.36%
Employee Cost %14.67%16.11%17.89%15.15%13.97%15.71%15.24%15.38%12.78%18.74%13.11%14.31%
Operating Profit47242315374245158155055
OPM %17%10%10%9%18%2%12%23%26%8%22%23%
Other Income4871316382021177091817
Interest000000000000
Depreciation666555754545
Profit before tax4426232348373767717206367
Tax %36%25%36%13%34%26%38%28%26%1%36%35%
Net Profit2819152032272348527154144
EPS in Rs17.1711.718.9312.1219.0916.4313.6829.1031.53430.9424.5226.56
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018TTM
Sales313387473509590687798867940993698849895
Sales Growth %-4.72%23.96%22.11%7.6%15.81%16.57%16.08%8.74%8.3%5.65%-29.66%21.61%%
Expenses246338412450503582721809855877621701717
Material Cost %40.47%41.29%43.56%40.83%41.18%43.51%45.5%46.16%46.33%41.46%33.94%31.73%%
Manufacturing Cost %6.27%6.51%6.54%6.06%6.99%5.5%7.76%7.46%6.64%5.91%9.36%8.11%%
Employee Cost %9.38%11.02%11.09%12.43%13.58%12.27%12.66%13.09%13.11%15.54%15.74%15.46%%
Other Cost %22.46%28.33%25.96%28.99%23.53%23.37%24.43%26.49%24.9%25.43%29.94%27.25%%
Operating Profit675061608710677598511677148178
OPM %21%13%13%12%15%15%10%7%9%12%11%17%20%
Other Income4048434317202120222474768761
Interest0000000000000
Depreciation76878910132325192118
Profit before tax10092969696117886783115132895922
Tax %31%31%32%34%33%33%37%35%36%31%29%6%
Net Profit6963656364785643547994839852
EPS in Rs37.7234.4036.0522.2838.3646.8332.2224.8430.7447.6756.57505.25513.55
Dividend Payout %49%47%51%250%0%5%25%23%23%23%27%87%

Compounded Sales Growth

  • 10 Years:: 8.16%
  • 5 Years:: 1.25%
  • 3 Years:: -3.32%
  • TTM:: 11.50%

Compounded Profit Growth

  • 10 Years:: 29.53%
  • 5 Years:: 71.59%
  • 3 Years:: 148.36%
  • TTM:: 555.84%

Return on Equity

  • 10 Years:: 24.58%
  • 5 Years:: 30.54%
  • 3 Years:: 40.36%
  • Last Year:: 73.25%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Jun 2019
Share Capital17171717171717171717171717
Equity Capital16.8616.8616.616.616.616.616.616.616.616.616.616.616.6
Reserves4064354513303934675065385756477171,524727
Borrowings0000000000000
Other Liabilities681131058595117132162203215258219229
Trade Payables20.0640.1635.1654.2529.3839.5937.4354.4867.4381.9587.0197.6767.48
Total Liabilities4915645724315056006557167948799911,759973
Fixed Assets38606349727585110132111115104104
Gross Block116.82140.58148.29153.6167.94178.38196.93231.72271.28143.96191.51190.81
Accumulated Depreciation78.7880.1385.4790.0596.44103.23112.1122.01139.5524.8251.2262.78
CWIP22120292873091714
Investments23415324202324242442287000
Other Assets2163494853604115005375556137117971,639855
Inventories36.2972.9858.4961.12113.09130.96151.82177.32166.86163.94157.74113.35130.54
Trade receivables31.1244.4443.8156.0862.1864.4284.12104.53126.57107.04122.6666.1779.65
Cash Equivalents116.91184.77324.64142.77113.28192.98187.69163.95188.42279.27278.181243.42426.35
Loans n Advances31.7946.5757.71100.173.8552.6436.5238.8164.3677.34154.58129.393.82
Other Assets etc000048.3358.8876.4870.0767.1583.2184.1286.2214.84
Total Assets4915645724315056006557167948799911,759973

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018
Cash from Operating Activity38442661954058310754-130
Profit from operations81.6170.4177.7698.5377.15108.9891.2287.6699.65130.05159.85223.89
Working Capital Changes-1.27-29.57-4.885.49-27.91-14.89-50.94-48.5315.6430.11-46.66-50.25
Taxes paid-42.23-36.95-31.14-38.05-30.45-39.83-39.83-34.18-31.82-53.12-59.53-304.02
Cash from Investing Activity21162176-9-82711-68-75-481,270
Fixed Assets Purchased-7.12-29.34-9.55-8.79-15.06-13.61-33.41-40.38-45.19-31.65-30.3-26.72
Fixed Assets Sold0.392.230.280.250.150.150.060.240.20.10.230.18
Investments purchased-1658.83-1485.34-828.75-954.22-566.76-731.99-854.76-911.33-990.30-42.20
Investments sold1673.591566.63957.96957.97564.2731.09854.11911.73971.9414.5070.87
Cash from Financing Activity-58-20-45-222-00-5-17-12-15-22-30
Dividends Paid-50.4-16.82-29.46-189.9400-4.15-14.22-9.93-12.45-18.26-24.9
Net Cash Flow2-0-22010-283-1417-161,109

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018
ROCE %24%21%21%24%25%26%18%12%15%18%16%78%
Debtor Days364234403834384449396428
Inventory Turnover8.657.097.208.516.775.635.645.275.466.004.346.26

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Procter Gamble Health Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.